Live feed
Filing
SC 13D/A
SC 13D/A0001144204-18-030719·Altamira Therapeutics Ltd.
Schedule 13D ownership disclosure
AURIS MED HLDG AG
Security class unavailable · CUSIP: H0381L104
Event date: 2018-05-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 258,534
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-030719
- Form type
- SC 13D/A
- Filer
- Altamira Therapeutics Ltd.
- CIK
- CIK 1601936
- Filed
- May 24, 2018
- Reporting period
- May 15, 2018
- Description
- Schedule 13D beneficial ownership